• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
T1 mapping in children and young adults with hypertrophic cardiomyopathy.肥厚型心肌病儿童及青年的T1映射
Int J Cardiovasc Imaging. 2017 Jan;33(1):109-117. doi: 10.1007/s10554-016-0979-9. Epub 2016 Sep 22.
2
Quantitative diffusion-weighted magnetic resonance imaging in the assessment of myocardial fibrosis in hypertrophic cardiomyopathy compared with T1 mapping.与T1 mapping相比,定量扩散加权磁共振成像在肥厚型心肌病心肌纤维化评估中的应用
Int J Cardiovasc Imaging. 2016 Aug;32(8):1289-97. doi: 10.1007/s10554-016-0909-x. Epub 2016 May 19.
3
Hypertrophic cardiomyopathy and left ventricular hypertrophy in hypertensive heart disease with mildly reduced or preserved ejection fraction: insight from altered mechanics and native T1 mapping.射血分数轻度降低或保留的高血压性心脏病中的肥厚型心肌病和左心室肥厚:来自力学改变和心肌T1 mapping的见解
Clin Radiol. 2017 Oct;72(10):835-843. doi: 10.1016/j.crad.2017.04.019. Epub 2017 May 25.
4
Effect of cellular and extracellular pathology assessed by T1 mapping on regional contractile function in hypertrophic cardiomyopathy.通过T1映射评估的细胞和细胞外病理学对肥厚型心肌病区域收缩功能的影响。
J Cardiovasc Magn Reson. 2017 Feb 20;19(1):16. doi: 10.1186/s12968-017-0334-x.
5
Systolic and diastolic myocardial mechanics in hypertrophic cardiomyopathy and their link to the extent of hypertrophy, replacement fibrosis and interstitial fibrosis.肥厚型心肌病的收缩期和舒张期心肌力学及其与肥厚程度、替代性纤维化和间质纤维化的关系。
Int J Cardiovasc Imaging. 2015 Dec;31(8):1603-10. doi: 10.1007/s10554-015-0720-0. Epub 2015 Jul 26.
6
T-Mapping and extracellular volume estimates in pediatric subjects with Duchenne muscular dystrophy and healthy controls at 3T.3T 下杜氏肌营养不良症患儿与健康对照者的 T 映射和细胞外容积评估。
J Cardiovasc Magn Reson. 2020 Dec 10;22(1):85. doi: 10.1186/s12968-020-00687-z.
7
Investigation of global and regional myocardial mechanics with 3-dimensional speckle tracking echocardiography and relations to hypertrophy and fibrosis in hypertrophic cardiomyopathy.应用三维斑点追踪超声心动图研究心肌整体和局部力学与肥厚型心肌病心肌肥厚和纤维化的关系。
Circ Cardiovasc Imaging. 2014 Jan;7(1):11-9. doi: 10.1161/CIRCIMAGING.113.000842. Epub 2013 Nov 25.
8
Histogram Analysis of Native T Mapping and Its Relationship to Left Ventricular Late Gadolinium Enhancement, Hypertrophy, and Segmental Myocardial Mechanics in Patients With Hypertrophic Cardiomyopathy.心肌肥厚症患者的 T 映射自然峰分析及其与左心室晚期钆增强、心肌肥厚和节段心肌力学的关系。
J Magn Reson Imaging. 2019 Mar;49(3):668-677. doi: 10.1002/jmri.26272. Epub 2018 Aug 24.
9
Altered regional myocardial velocities by tissue phase mapping and feature tracking in pediatric patients with hypertrophic cardiomyopathy.组织相位图和特征追踪技术评价肥厚型心肌病患儿局部心肌速度改变。
Pediatr Radiol. 2020 Feb;50(2):168-179. doi: 10.1007/s00247-019-04549-4. Epub 2019 Oct 28.
10
T1 Mapping in Discrimination of Hypertrophic Phenotypes: Hypertensive Heart Disease and Hypertrophic Cardiomyopathy: Findings From the International T1 Multicenter Cardiovascular Magnetic Resonance Study.T1 Mapping在肥厚型表型鉴别中的应用:高血压性心脏病和肥厚型心肌病:国际T1多中心心血管磁共振研究结果
Circ Cardiovasc Imaging. 2015 Dec;8(12). doi: 10.1161/CIRCIMAGING.115.003285.

引用本文的文献

1
Mexican guidelines 2024 for the diagnosis and treatment of hypertrophic cardiomyopathy.《2024年墨西哥肥厚型心肌病诊断与治疗指南》
Arch Cardiol Mex. 2024;94(Supl 4):1-75. doi: 10.24875/ACM.M25000098.
2
Society for Cardiovascular Magnetic Resonance reference values ("normal values") in cardiovascular magnetic resonance: 2025 update.心血管磁共振学会心血管磁共振参考值(“正常值”):2025年更新。
J Cardiovasc Magn Reson. 2025;27(1):101853. doi: 10.1016/j.jocmr.2025.101853. Epub 2025 Feb 4.
3
Elevated septal native T1 time in cardiac magnetic resonance imaging suggesting myocardial fibrosis in young kidney transplant recipients.心脏磁共振成像中室间隔固有T1时间升高提示年轻肾移植受者存在心肌纤维化。
J Cardiovasc Magn Reson. 2025 Jan 13;27(1):101839. doi: 10.1016/j.jocmr.2025.101839.
4
Differentiation of Myocardial Properties in Physiological Athletic Cardiac Remodeling and Mild Hypertrophic Cardiomyopathy.生理性运动性心脏重塑和轻度肥厚型心肌病中心肌特性的分化
Biomedicines. 2024 Feb 12;12(2):420. doi: 10.3390/biomedicines12020420.
5
Cardiac MRI in diagnosis, prognosis, and follow-up of hypertrophic cardiomyopathy in children: current perspectives.心脏 MRI 在儿童肥厚型心肌病的诊断、预后和随访中的应用:当前观点。
Br J Radiol. 2024 May 7;97(1157):875-881. doi: 10.1093/bjr/tqae033.
6
Fabry Disease: More than a Phenocopy of Hypertrophic Cardiomyopathy.法布里病:不仅仅是肥厚型心肌病的拟表型
J Clin Med. 2023 Nov 13;12(22):7061. doi: 10.3390/jcm12227061.
7
Functional significance of myocardial activity at F-FAPI PET/CT in hypertrophic cardiomyopathy identified by cardiac magnetic resonance feature-tracking strain analysis.心肌磁共振特征追踪应变分析识别肥厚型心肌病 F-FAPI PET/CT 心肌活性的功能意义。
Eur J Nucl Med Mol Imaging. 2023 Dec;51(1):110-122. doi: 10.1007/s00259-023-06411-0. Epub 2023 Aug 29.
8
Myocardial tissue characterization by cardiovascular magnetic resonance T1 mapping and pericardial fat quantification in adolescents with morbid obesity. Cardiac dimorphism by gender.通过心血管磁共振T1成像对病态肥胖青少年的心肌组织特征进行表征及心包脂肪定量分析。按性别划分的心脏二态性。
Int J Cardiovasc Imaging. 2023 Apr;39(4):781-792. doi: 10.1007/s10554-022-02773-y. Epub 2022 Dec 12.
9
Native T1 mapping detects both acute clinical rejection and graft dysfunction in pediatric heart transplant patients.原发性 T1 映射可检测儿科心脏移植患者的急性临床排斥反应和移植物功能障碍。
J Cardiovasc Magn Reson. 2022 Oct 3;24(1):51. doi: 10.1186/s12968-022-00875-z.
10
SCMR expert consensus statement for cardiovascular magnetic resonance of acquired and non-structural pediatric heart disease.SCMR 专家共识声明:获得性和非结构性儿科心脏病的心血管磁共振成像。
J Cardiovasc Magn Reson. 2022 Jul 21;24(1):44. doi: 10.1186/s12968-022-00873-1.

本文引用的文献

1
T1 Mapping in Discrimination of Hypertrophic Phenotypes: Hypertensive Heart Disease and Hypertrophic Cardiomyopathy: Findings From the International T1 Multicenter Cardiovascular Magnetic Resonance Study.T1 Mapping在肥厚型表型鉴别中的应用:高血压性心脏病和肥厚型心肌病:国际T1多中心心血管磁共振研究结果
Circ Cardiovasc Imaging. 2015 Dec;8(12). doi: 10.1161/CIRCIMAGING.115.003285.
2
Intracranial Gadolinium Deposition after Contrast-enhanced MR Imaging.颅内钆沉积与对比增强磁共振成像后。
Radiology. 2015 Jun;275(3):772-82. doi: 10.1148/radiol.15150025. Epub 2015 Mar 5.
3
Quantification and significance of diffuse myocardial fibrosis and diastolic dysfunction in childhood hypertrophic cardiomyopathy.儿童肥厚型心肌病中弥漫性心肌纤维化和舒张功能障碍的量化及意义
Pediatr Cardiol. 2015 Jun;36(5):970-8. doi: 10.1007/s00246-015-1107-7. Epub 2015 Jan 21.
4
Mapping the future of cardiac MR imaging: case-based review of T1 and T2 mapping techniques.描绘心脏磁共振成像的未来:基于病例的T1和T2映射技术综述
Radiographics. 2014 Oct;34(6):1594-611. doi: 10.1148/rg.346140030.
5
T1 Mapping for Characterization of Intracellular and Extracellular Myocardial Diseases in Heart Failure.用于心力衰竭中细胞内和细胞外心肌疾病特征描述的T1映射
Curr Cardiovasc Imaging Rep. 2014;7(9):9287. doi: 10.1007/s12410-014-9287-8.
6
Subclinical Myocardial Disease in Heart Failure Detected by CMR.通过心脏磁共振成像检测到的心力衰竭中的亚临床心肌疾病
Curr Cardiovasc Imaging Rep. 2014 Apr;7:9269. doi: 10.1007/s12410-014-9269-x.
7
In-vivo T1 cardiovascular magnetic resonance study of diffuse myocardial fibrosis in hypertrophic cardiomyopathy.肥厚型心肌病弥漫性心肌纤维化的体内 T1 心血管磁共振研究。
J Cardiovasc Magn Reson. 2014 Apr 25;16(1):28. doi: 10.1186/1532-429X-16-28.
8
Diffuse myocardial fibrosis following tetralogy of Fallot repair: a T1 mapping cardiac magnetic resonance study.法洛四联症修复术后的弥漫性心肌纤维化:一项T1映射心脏磁共振研究。
Pediatr Radiol. 2014 Apr;44(4):403-9. doi: 10.1007/s00247-013-2840-9. Epub 2014 Jan 14.
9
T1-mapping in the heart: accuracy and precision.心脏 T1-mapping:准确性和精密度。
J Cardiovasc Magn Reson. 2014 Jan 4;16(1):2. doi: 10.1186/1532-429X-16-2.
10
Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement.心肌 T1 映射和细胞外容积定量:心血管磁共振学会 (SCMR) 和欧洲心脏病学会 CMR 工作组的共识声明。
J Cardiovasc Magn Reson. 2013 Oct 14;15(1):92. doi: 10.1186/1532-429X-15-92.

肥厚型心肌病儿童及青年的T1映射

T1 mapping in children and young adults with hypertrophic cardiomyopathy.

作者信息

Parekh Keyur, Markl Michael, Deng Jie, de Freitas Roger A, Rigsby Cynthia K

机构信息

Department of Medical Imaging, Ann and Robert H. Lurie Children's Hospital of Chicago, 225 East Chicago Avenue, Chicago, IL, 60611, USA.

Department of Radiology, Feinberg School of Medicine, Northwestern University, 225 East Chicago Avenue, Chicago, IL, 60611, USA.

出版信息

Int J Cardiovasc Imaging. 2017 Jan;33(1):109-117. doi: 10.1007/s10554-016-0979-9. Epub 2016 Sep 22.

DOI:10.1007/s10554-016-0979-9
PMID:27659477
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5250557/
Abstract

To assess the global and segmental left ventricular (LV) native T1 and extracellular volume fraction (ECV) in children and young adults with hypertrophic cardiomyopathy (HCM) compared to a control cohort. The study population included 21 HCM patients (mean 14.1 ± 4.6 years) and 21 controls (mean 15.7 ± 1.5 years). Native modified Look-Locker inversion recovery sequence was performed before and after contrast injection in 3 short axis planes. Global and segmental LV native T1 and ECV were quantified and compared between HCM patients and controls. Mean native T1 in HCM patients and controls was 1020.4 ± 41.2 and 965.6 ± 30.2 ms respectively (p < 0.0001). Hypertrophied myocardium had significantly higher native global T1 and global ECV compared to non-hypertrophied myocardium in HCM (p < 0.0001, = 0.14 and 0.048, = 0.01 respectively). In a subset of patients, ECV was higher in LV segments with LGE compared to no LGE (p < 0.0001). No significant correlation was identified between global native T1 and ECV and parameters of LV structure and function. Native T1 cut-off of 987 ms provided the highest sensitivity (95 %) and specificity (91 %) to separate HCM patients from controls. Global and segmental native T1 are elevated in HCM patients. LV segments with hypertrophy and/or LGE had higher ECV in a subset of HCM patients. LV native T1 and ECV do not correlate with parameters of LV structure and function. T1 in children and young adults may be used as a non-invasive tool to assess for HCM and related fibrosis.

摘要

为评估肥厚型心肌病(HCM)患儿及青年人与对照组相比左心室(LV)整体及节段性的固有T1和细胞外容积分数(ECV)。研究人群包括21例HCM患者(平均14.1±4.6岁)和21名对照组(平均15.7±1.5岁)。在3个短轴平面上于注射造影剂前后进行固有改良Look-Locker反转恢复序列检查。对HCM患者和对照组的左心室整体及节段性固有T1和ECV进行定量并比较。HCM患者和对照组的平均固有T1分别为1020.4±41.2和965.6±30.2毫秒(p<0.0001)。与HCM中未肥厚的心肌相比,肥厚心肌的固有整体T1和整体ECV显著更高(p<0.0001,分别为0.14和0.048,0.01)。在一部分患者中,有心肌梗死延迟增强(LGE)的左心室节段的ECV高于无LGE的节段(p<0.0001)。未发现整体固有T1和ECV与左心室结构和功能参数之间存在显著相关性。987毫秒的固有T1临界值在区分HCM患者与对照组时具有最高的敏感性(95%)和特异性(91%)。HCM患者的整体及节段性固有T1升高。在一部分HCM患者中,有肥厚和/或LGE的左心室节段具有更高的ECV。左心室固有T1和ECV与左心室结构和功能参数无关。儿童和青年的T1可用作评估HCM及相关纤维化的非侵入性工具。